Sinovac’s application for conditional market launch of its inactivated vaccine has been accepted by China’s drug regulator
The COVID-19 vaccine Beijing manufacturing plant of leading Chinese vaccine producer Sinovac Photo: Li Hao/GT
Sinovac’s application for conditional market launch of its inactivated vaccine has been accepted by China’s drug regulator
